OrthoPediatrics (NASDAQ:KIDS) reported fourth-quarter 2025 results that management said capped a strong year of growth and ...
This is going to be probably the strongest de novo year that we have had since I have been with the company, so de novos are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results